This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
FEW PEOPLE today are better qualified to go out on the shaky limb of predicting progress in the war against cancer than Vincent T. DeVita, Jr, MD. And no time has been as good as today for going out on that limb, now that scientists have a good idea of how cells become cancerous. DeVita, a highly decorated five-star general in the campaign to conquer cancer, has been on the front lines since before the passage of the National Cancer Act of 1971, which was a turning point, he says, in the long and bitter struggle to defeat the disease.
DeVita, now director of the Yale Cancer Center and professor of epidemiology and public health and professor of medicine at Yale University School of Medicine, New Haven, Conn, has witnessed, and played a large part in, the development of a wealth of research tools that has at last pried open
Skolnick AA. Leader in War on Cancer Looks Ahead: Talking With Vincent T. DeVita, Jr, MD. JAMA. 1995;273(7):525-527. doi:10.1001/jama.1995.03520310019018